Compass Therapeutics (CMPX) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $177.6 million.
- Compass Therapeutics' Shares Outstanding rose 2905.97% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.6 million, marking a year-over-year increase of 2905.97%. This contributed to the annual value of $137.8 million for FY2024, which is 795.19% up from last year.
- Per Compass Therapeutics' latest filing, its Shares Outstanding stood at $177.6 million for Q3 2025, which was up 2905.97% from $138.3 million recorded in Q2 2025.
- Over the past 5 years, Compass Therapeutics' Shares Outstanding peaked at $177.6 million during Q3 2025, and registered a low of $126.4 million during Q1 2023.
- In the last 3 years, Compass Therapeutics' Shares Outstanding had a median value of $137.6 million in 2024 and averaged $137.6 million.
- Examining YoY changes over the last 5 years, Compass Therapeutics' Shares Outstanding showed a top increase of 2905.97% in 2025 and a maximum decrease of 50.37% in 2025.
- Over the past 3 years, Compass Therapeutics' Shares Outstanding (Quarter) stood at $127.7 million in 2023, then increased by 7.95% to $137.8 million in 2024, then grew by 28.84% to $177.6 million in 2025.
- Its last three reported values are $177.6 million in Q3 2025, $138.3 million for Q2 2025, and $138.3 million during Q1 2025.